OÜ PharmaFifteen
CopyRegistry data
Legal status
Company ID
14915654VAT code
EE102233843Registered
19/02/2020Share capital
2,500.00 €Contacts
Company registration address
Website
-
C
AverageReliability
C - Average
0 ** during past year
Number of employees
8Credit limit
30-50 k €Credit report
Company's financial performance and creditability assessment.
+75.09 % ** during past year
Taxes
16.3KDebts
-+9.97 % ** during past year
Taxable turnover
1.3M
Name, Surname  | Title | Start date | End date | Linkages |
|---|---|---|---|---|
Data is only provided to registered users with a legitimate interest. |
Financial ratios
Net Profit (€)
Register and
explore Okredo data
EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization and is a metric used to evaluate a company’s operating performance. It can be seen as a proxy for cash flow from the entire company’s operations.EBITDA margin (%)
Register and
explore Okredo dataEBIT margin shows the profitability of a company over a certain period of time.EBIT margin (%)
Register and
explore Okredo dataNet Profit (€)
Register and
explore Okredo dataEBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo dataFinancial statement report (Okredo)
Premium users: 1.00 credit
| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€)Sales per employee is a popular efficiency indicator that is often used to measure a company's performance. The average annual number of employees is usually used to calculate the indicator. |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€)This ratio is on of company's growth indicators. It shows how much profit per employee is earned by the company. |
| Working capital requirement (%)The working capital requirement indicator shows how much funds a company needs to develop and maintain a business. |
| Debt-to-equity ratioThe debt-to-equity ratio is used to evaluate a company's financial leverage and is calculated by dividing a company’s total liabilities by its shareholder equity.
This ratio is a measure of the degree to which a company is financing its operations through debt versus wholly owned funds. More specifically, it reflects the ability of shareholder equity to cover all outstanding debts in the event of a business downturn. |
| EBITDA margin (%)EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization and is a metric used to evaluate a company’s operating performance. It can be seen as a proxy for cash flow from the entire company’s operations. |
| EBITDA (€)EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. Lenders use EBITDA to calculate a company’s ability to repay a loan and pay interest. |
| EBIT margin (%)EBIT margin shows the profitability of a company over a certain period of time. |
| EBIT (€)EBIT (earnings before interest and taxes) is a company's net income before income tax expense and interest expenses are deducted. EBIT is used to analyze the performance of a company's core operations without the costs of the capital structure and tax expenses impacting profit. |
| Total profitability (%)It is an indicator of company's performance efficiency, calculated as ratio of gross profit to sales revenue. |
| Net profitability (%)This ratio is commonly referred to as a company’s “bottom line” and is a true indicator of a company’s profitability. It shows how much a net profit of € 1 (or other monetary unit) is generated by sales. |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| Current Assets (€) |
| 2022 |
|---|
| 4,134,318 |
| 826,864 |
| 20,572 |
| 20,572 |
| 4,114 |
| -0.27 |
| -26.48 |
| 10.83 |
| 447,573 |
| 7.38 |
| 305,029 |
| 14.33 |
| 0.50 |
| -80,441 |
| 2,129,892 |
| 1,031,499 |
| 1,017,952 |
| 2023 |
|---|
| 4,711,887 |
| 588,986 |
| 1,710 |
| 1,710 |
| 214 |
| -0.18 |
| -22.25 |
| 7.70 |
| 362,776 |
| 5.27 |
| 248,105 |
| 12.20 |
| 0.04 |
| -78,731 |
| 1,751,673 |
| 781,422 |
| 891,520 |
| 2024 |
|---|
| 4,683,989 |
| 425,817 |
| -37,046 |
| -37,046 |
| -3,368 |
| -0.16 |
| -13.67 |
| 6.07 |
| 284,535 |
| 3.41 |
| 159,805 |
| 13.18 |
| -0.79 |
| -115,777 |
| 1,582,491 |
| 656,691 |
| 810,023 |
| 2024 |
|---|
| 4,683,989 |
| 425,817 |
| -37,046 |
| -37,046 |
| -3,368 |
| -0.16 |
| -13.67 |
| 6.07 |
| 284,535 |
| 3.41 |
| 159,805 |
| 13.18 |
| -0.79 |
| -115,777 |
| 1,582,491 |
| 656,691 |
| 810,023 |
Register and
explore Okredo dataTurnover (€)
Register and
explore Okredo dataCredit history
No. of unpaid debts
0
Largest debt
-
Amount of unpaid debts
€0.00
Oldest open debt
-
No. of unpaid debts
0
Largest debt
-
Amount of unpaid debts
€0.00
Oldest open debt
-
Credit report
Creditor/Data source | Debt amount | Debt date | Debt type |
|---|---|---|---|
- | - | - | - |
Creditor/Data source | Debt amount | Debt date | Payment date | Debt type |
|---|---|---|---|---|
- | - | - | - | - |
Credit report
It is a professional assessment of the company 's performance, revealing company's potential and risks, showing it's past experiences and revealing future prospects.
Example report (PDF)
Similar companies
Category:
Retail sale of pharmaceutical productsComp. code:
16840009Reg. date:
13/10/2023Turnover:
-No. of employees:
8Category:
Retail sale of pharmaceutical productsComp. code:
16009865Reg. date:
15/07/2020Turnover:
-No. of employees:
14Category:
Retail sale of pharmaceutical productsComp. code:
16009799Reg. date:
15/07/2020Turnover:
-No. of employees:
7Category:
Retail sale of pharmaceutical productsComp. code:
14988044Reg. date:
11/06/2020Turnover:
-No. of employees:
9Category:
Retail sale of pharmaceutical productsComp. code:
14945023Reg. date:
30/03/2020Turnover:
-No. of employees:
7